Download PDF
Semin Respir Crit Care Med 2001; 22(2): 165-174
DOI: 10.1055/s-2001-13830
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Use of Sedative Medications in the Intensive Care Unit

Stanley A. Nasraway Jr.
  • Department of Surgery, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

Current choices for sustained sedation in the critically ill include the benzodiazepines, the opiates, and propofol. Each of these groups of medications has their particular benefits: benzodiazepines provide the greatest amnesia, opiates are the only agents to provide analgesia, and propofol is the most easily titratable and the least likely to excessively accrue. The literature seems to favor propofol over the benzodiazepines as the most cost-effective solution to sustained sedation. A newly approved agent, dexmedetomidine, holds promise as a continuous infusion that can provide both anxiolysis and analgesia, but without the ventilatory depression seen in the other classes of sedatives. Further research is needed to determine the role of dexmedetomidine in the ICU. The emerging standard of care for sustained sedation is the use of standardized protocols, formulated with the help of clinical practice guidelines, and titrated with the guidance of sedation monitoring.

KEYWORD

Dexmedetomidine - benzodiazepines - propofol

REFERENCES

  • 1 Shapiro B A, Warren J, Egol A B. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary.  Crit Care Med . 1995;  23 1596-1600
    CrossrefPubMedGoogle Scholar
  • 2 Schelling G, Stoll C, Haller M. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome.  Crit Care Med . 1998;  26 651-659
    CrossrefPubMedGoogle Scholar
  • 3 Krachman S L, D'Alonzo G E, Criner G J. Sleep in the intensive care unit.  Chest . 1995;  107 1713-1720
    PubMedGoogle Scholar
  • 4 Meyer T J, Eveloff S E, Bauer M S, Schwartz W A, Hill N S, Millman R P. Adverse environmental conditions in the respiratory and medical ICU settings.  Chest . 1994;  105 1211-1216
    CrossrefPubMedGoogle Scholar
  • 5 Schein R MH, Hazday N, Pena M, Ruben B H, Sprung C L. Clinical antecedents to in-hospital cardiopulmonary arrest.  Chest . 1990;  98 1388-1392
    CrossrefPubMedGoogle Scholar
  • 6 Franklin C, Mathew J. Developing strategies to prevent inhospital cardiac arrest: analyzing responses of physicians and nurses in the hours before the event.  Crit Care Med . 1994;  22 244-247
    CrossrefPubMedGoogle Scholar
  • 7 Johnson K L, Cheung R B, Johnson S B, Roberts M, Niblett J, Manson D. Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members.  Am J Crit Care . 1999;  8 490-498
    PubMedGoogle Scholar
  • 8 Bailie G R, Cockshott I D, Douglas E J, Bowles B J. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients.  Br J Anaesth . 1992;  68 486-491
    PubMedGoogle Scholar
  • 9 Langley M S, Heel R C. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anesthetic.  Drugs . 1988;  35 334-372
    CrossrefPubMedGoogle Scholar
  • 10 MacKenzie S J, Kapadia F, Grant I S. Propofol infusion for control of status epilepticus.  Anaesthesia . 1990;  45 1043-1045
    PubMedGoogle Scholar
  • 11 Brown L A, Levin G M. Role of propofol in refractory status epilepticus.  Ann Pharmacother . 1998;  32 1053-1059
    PubMedGoogle Scholar
  • 12 Kelly D F, Goodale D B, Williams J. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial.  J Neurosurg. . 1999;  90 1042-1052
    CrossrefPubMedGoogle Scholar
  • 13 Wagner B KJ, O'Hara D A, Hammond J S. Drugs for amnesia in the ICU.  Am J Crit Care . 1997;  6 192-201
    PubMedGoogle Scholar
  • 14 McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series.Crit Care Med.  . 2000;  28(6) 1781-1784
    PubMedGoogle Scholar
  • 15 Coomes T R, Smith S W. Successful use of propofol in refractory delirium tremens.  Ann Emerg Med. . 1997;  30(6) 825-828
    PubMedGoogle Scholar
  • 16 Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol.  Clin Pharmacokinet . 1989;  17 308-326
    PubMedGoogle Scholar
  • 17 Kowalski S D, Rayfield C A. A post hoc descriptive study of patients receiving propofol.  Am J Crit Care . 1999;  8 507-513
    PubMedGoogle Scholar
  • 18 Foex P, Diedericks J, Sear J W. Cardiovascular effects of propofol.  J Drug Dev . 1991;  4(suppl 3) 3-9
    PubMedGoogle Scholar
  • 19 Carrasco G, Molina R, Costa J. Propofol versus midazolam in short-, medium-, and long-term sedation of critically ill patients.  Chest . 1993;  103 557-564
    CrossrefPubMedGoogle Scholar
  • 20 Kumar A N, Achwartz D E, Lim K G. Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge.  Chest . 1999;  115 1198-1199
    CrossrefPubMedGoogle Scholar
  • 21 Bennett S N, McNeil M M, Bland L A. Postoperative infections traced to contamination of an intravenous anesthetic, propofol.  N Engl J Med . 1995;  333 147-154
    CrossrefPubMedGoogle Scholar
  • 22 Webb S A, Roberts B, Breheny F X, Golledge C L, Cameron P D, van Heerden P V. Contamination of propofol infusions in the intensive care unit: incidence and clinical significance.  Anaesth Intensive Care . 1998;  26 162-164
    PubMedGoogle Scholar
  • 23 Valente J F, Anderson G L, Branson R D, Johnson D J, Davis K, Porembka D T. Disadvantages of prolonged propofol sedation in the critical care unit.  Crit Care Med . 1994;  22 710-712
    PubMedGoogle Scholar
  • 24 Au J, Walker W S, Scott D HT. Withdrawal syndrome after propofol infusion.  Anaesthesia . 1990;  45 741-742
    CrossrefPubMedGoogle Scholar
  • 25 Bodenham A, Culank L S, Park G R. Propofol infusion and green urine.  Lancet . 1987;  2 740
    PubMedGoogle Scholar
  • 26 Greenblatt D J. Sedation: intravenous benzodiazepines in critical care medicine. In:Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient.  3rd ed. Baltimore: Williams & Wilkins 1994: 321-326
    Google Scholar
  • 27 Gilliland H EM, Prasad B K, Mirakhur R K, Fee J PH. An investigation of the potential morphine sparing effect of midazolam.  Anaesthesia . 1996;  51 808-811
    PubMedGoogle Scholar
  • 28 Ostermann M E, Keenan S P, Seiferling R A, Sibbald W J. Sedation in the intensive care unit: a systematic review.  JAMA . 2000;  283 1451-1459
    CrossrefPubMedGoogle Scholar
  • 29 Kress J P, Pohlman A S, O'Connor M F, Hall J B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.  New Engl J Med . 2000;  342 1471-1477
    CrossrefPubMedGoogle Scholar
  • 30 Kollef M H, Levy N T, Ahrens T S, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation.  Chest . 1998;  114 541-548
    CrossrefPubMedGoogle Scholar
  • 31 Hojer J, Baehrendtz S, Magnusson A, Gustafsson L L. A placebo controlled trial of flumazenil given by continuous infusion in severe benzodiazepine overdosage.  Acta Anaesthesiol Scand . 1991;  35 584-590
    PubMedGoogle Scholar
  • 32 Shelly M P, Sultan M A, Bodenham A, Park G R. Midazolam infusions in critically ill patients.  Eur J Anaesthesiol . 1991;  8 21-27
    PubMedGoogle Scholar
  • 33 Cammarano W B, Pittet J-F, Weitz S, Schlobohm R M, Marks J D. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients.  Crit Care Med . 1998;  26 676-684
    CrossrefPubMedGoogle Scholar
  • 34 Finley P R, Nolan P E. Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam.  Annals of Pharmacotherapy . 1989;  23 151-152
    PubMedGoogle Scholar
  • 35 Grossman M, Abiose A, Tangphao O. Morphine-induced venodilation in humans.  Clin Pharmacol Ther . 1996;  60 554-560
    CrossrefPubMedGoogle Scholar
  • 36 Flacke J W, Flacke W E, Bloor B C, Van Etten P A, Kripke B J. Histamine release by four narcotics: a double-blind study in humans.  Anesth Analg . 1987;  66 723-730
    PubMedGoogle Scholar
  • 37 McArdle P Intravenous analgesia. Crit Care Clinics .  1999;  15 89-105
    PubMedGoogle Scholar
  • 38 Balestrieri F, Fisher S. Analgesics. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient 3rd ed. Baltimore: Williams & Wilkins 1994: 640-650
    Google Scholar
  • 39 Smith D C, Bergen J M, Smithline H, Kirschner R. A trial of etomidate for rapid sequence intubation in the emergency department.  J Emerg Med . 2000;  18 13-16
    CrossrefPubMedGoogle Scholar
  • 40 Migden D R, Reardon R F. Etomidate sedation for intubation.  Am J Emerg Med . 1998;  16 101-102
    CrossrefPubMedGoogle Scholar
  • 41 Van Hamme J M, Ghoneim N M, Amber J J. Pharmacokinetics of etomidate, a new intravenous anesthetic.  Anesthesiol . 1978;  49 274
    PubMedGoogle Scholar
  • 42 Wagner R L, White P F. Etomidate inhibits adrenocortical function in surgical patients.  Anesthesiol . 1984;  60 647
    PubMedGoogle Scholar
  • 43 Kress J P, O'Connor M F, Pohlman A S. Sedation of critically ill patients during mechanical ventilation.  Am J Resp Crit Care Med . 1996;  153 1012-1018
    PubMedGoogle Scholar
  • 44 McCollam J S, O'Neil M G, Norcross E D, Byrne T K, Reeves S T. Continuous infusions of lorazepam, midazolam and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.  Crit Care Med . 1999;  27 2454-2458
    CrossrefPubMedGoogle Scholar
  • 45 Barrientos-Vega R, Sanchez-Soria M M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.  Crit Care Med . 1997;  25 33-40
    CrossrefPubMedGoogle Scholar
  • 46 Chamorro C, DeLatorre F J, Montero A. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.  Crit Care Med . 1996;  24 932-939
    CrossrefPubMedGoogle Scholar
  • 47 Pohlman A S, Simpson K P, Hall J B. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study.  Crit Care Med . 1994;  22 1241-1247
    CrossrefPubMedGoogle Scholar
  • 48 Weinbroum A A, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.  Intensive Care Med . 1997;  23 1258-1263
    CrossrefPubMedGoogle Scholar
  • 49 Sanchez-Izquierdo-Riera J A, Caballero-Cubedo R E, Perez-Vela J L, Ambros-Checa A, Cantalapiedra-Santiago J A, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient.  Anesth Analg . 1998;  86 1219-1224
    CrossrefPubMedGoogle Scholar
  • 50 Swart E, Strack van Schijndel J M R, van Loenen C A, Thijs L G. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost effective.  Crit Care Med . 1999;  27 1461-1465
    CrossrefPubMedGoogle Scholar
  • 51 Jacobi J, Bjerke H S, Chalfin D. Revised clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.  Crit Care Med 2001 (in press).
    PubMedGoogle Scholar
  • 52 Brook A D, Ahrens T S, Schaiff R, Prentice D, Sherman G, Shannon W. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation.  Crit Care Med . 1999;  27 2609-2615
    CrossrefPubMedGoogle Scholar
  • 53 Eisenach J C, DeKock M, Klimscha W. Alpha-2-adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984-1995).  Anesthesiology . 1996;  85 655-674
    CrossrefPubMedGoogle Scholar
  • 54 Kamibayashi T, Maze M. Clinical uses of α2-adrenergic agonists.  Anesthesiology . 2000;  93 1345-1349
    CrossrefPubMedGoogle Scholar
  • 55 Franowicz J S, Arnsten A F. The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys.  Psychopharmacology . 1998;  136 8-14
    CrossrefPubMedGoogle Scholar
  • 56 Hall J E, Uhrich T D, Barney J A, Arain S R, Ebert T J. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.  Anesth Analg . 2000;  90 699-705
    CrossrefPubMedGoogle Scholar
  • 57 Venn R M, Bradshaw C J, Spencer R. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit.  Anaesthesia . 1999;  54 1136-1142
    CrossrefPubMedGoogle Scholar
  • 58 Precedex (dexmedetomidine hydrochloride injection), package insert. Manufactured by Abbott Laboratories, North Chicago, IL, February 2000
    Google Scholar
  • 59 Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha-2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.  Anesthesiol . 1998;  89 574-584
    PubMedGoogle Scholar
  • 60 Maze M, Virtanen R, Daunt D, Banks S J, Stover E P, Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anethetic agent, on adrenal steroidogenesis: in vivo and in vitro studies.  Anesth Analg . 1991;  73 204-208
    PubMedGoogle Scholar
  • 61 Bhana N, Goa K L, McClellan K J. Dexmedetomidine.  Drugs . 2000;  59 263-268
    CrossrefPubMedGoogle Scholar
  • 62 Bachand R, Scholz J, Pinaud M. The effects of dexmedetomidine in patients in the intensive care setting.  Intensive Care Medicine . 1999;  25(suppl 1) S160
    PubMedGoogle Scholar
  • 63 Martin E, Lehot J J, Manikis P. Dexmedetomidine: a novel agent for patients in the intensive care setting.  Intensive Care Medicine . 1999;  25(suppl 1) S160
    PubMedGoogle Scholar
  • 64 Nasraway S A, Jacobi J, Murray M J. Sedation, analgesia and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2001.  Crit Care Med 2001; in press.
    PubMedGoogle Scholar
  • 65 Riker R R, Picard J T, Fraser G L. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients.  Crit Care Med . 1999;  27 1325-1329
    CrossrefPubMedGoogle Scholar
  • 66 Luce J. Reducing the use of mechanical ventilation.  N Engl J Med . 1996;  335 1916-1917
    CrossrefPubMedGoogle Scholar
  • 67 Mascia M F, Koch M, Medicis J J. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation and neuromuscular blockade in critical care.  Crit Care Med . 2000;  28 2300-2306
    PubMedGoogle Scholar
      >